Loading...

KIMIABL Kimia Biosciences Ltd Investments/Divestments Announcement

Km B

KMBL

Kimia Biosciences Ltd

(KIMIABL)

2023 Announcement

Show Summary

Show Summary

Revised Financial Statement

Financial Results Correction

Regulation Non-Applicability

Financial Results Published

Auditor Resignation

CFO Resignation

Statutory Auditor Appointment

Compliance Certificate

Corporate Governance Update

Promoter Shareholding Discl...

Corporate Governance Exemption

Financial Results Published

Compliance Report

Management Appointment

Investor Complaints Update

Compliance Certificate

AGM Notice Published

Board Meeting Outcome

Financial Results

New Appointment

Regulatory Update

Order Clarification

AGM Time Extension

Financial Results Published

Management Change

Quality Product Filing

Certificate Submission

Appointment of Auditor

Board Meeting Outcome

Financial Results Publication

Resignation of Auditors

Resignation of Auditor

Senior Appointment

Appointment of COO

Compliance Certificate Subm...

Compliance Certificate Subm...

Confirmation of Active Subs...

Certificate Submission

Confirmation Letter

Financial Results

Certificate Submission

Withdrawal of Contribution

Non-Compliance of Regulatio...

Trademark Registration

Certificate Submission

Incorporation of LLP

Appointment of Director

Newspaper Advertisement

Management Change

Appointment of Non-Executiv...

Financial Statements

Financial Statements

Financial Statements

Financial Statements Public...

Debt Securities

External Links:

Data:

Kimia Biosciences Ltd filed an application for grant of patent for an improved process for the preparation of AP product Luliconazole, which has been published by the World Intellectual Property Organization (WIPO).

AI Assistant

Kimia Biosciences Ltd

2023

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.